Table 3.
Visual and refractive outcomes, intraocular pressure (IOP), endothelial cell density (ECD), and vault of the different studies considered (mean, standard deviation, and range) NR: not reported.
| Author | UCVA (logMAR) | CDVA (logMAR) | Safety index | Efficacy index | ±0.50D (% eyes) | ±1.00D (% eyes) | SE (D) | IOP (mmHg) (eyes >21) | ECD (cells/m2) (% loss) | Vault (μm) |
|---|---|---|---|---|---|---|---|---|---|---|
| Lisa et al. [5] | 0.028 ± 0.055 | 0.003 ± 0.013 | 1.04 | 1.00 | 93.9 | 100 | −0.14 ± 0.26 | 12.4 ± 1.4 (0 > 20) | 2650 ± 438 (1.7) | 405.5 ± 184.7 (100 to 980) |
| Karandikar et al. [6] | NR | NR | 1.15 | 1.6 | 57.12 | 98.12 | −0.19 ± 1.18 | 19.1 ± 1.3 | NR (7.1) | 628.2 ± 300.1 (NR) |
| Ganesh et al. [7] | −0.022 ± 0.021 | −0.071 ± 0.079 | 1.24 | 1.12 | 90 | 100 | −0.164 ± 0.20 | NR | 2808 ± 315 (9.0) | NR |
| Pjano et al. [8] | 0.76 ± 0.16 (decimal) | 0.79 ± 0.14 (decimal) | 1.25 | 1.2 | NR | NR | −0.21 ± 0.27 | 14.96 ± 1.7 | 2512 ± 127 (5.5) | NR |
| Kamiya et al. [9] | ||||||||||
| Low-to-moderate myopia | −0.17 ± 0.14 | −0.21 ± 0.10 | NR | NR | 93 | 98 | −0.12 | 13.1 (0) | NR (0.1) | NR |
| High myopia | −0.16 ± 0.09 | −0.21 ± 0.08 | NR | NR | 94 | 99 | 0.02 | 13.6 (0) | NR (0.1) | NR |
| García-de la Rosa et al. [10] | 0.12 ± 0.12 | 0.05 ± 0.08 | NR | NR | 85 | 86 | −0.06 ± 0.77 | NR | NR | 449 ± 180 (NR) |
| Niu et al. [11] | 0.89 ± 0.30 (decimal) | 1.00 ± 0.27 (decimal) | 1.33 | 1.14 | 69 | 92 | −0.67 ± 1.29 | 15.15 ± 2.57 (0) | 2963 ± 396 (8.38) | 380 ± 152 (90 to 700) |
| Sachdev et al. [12] | 0 ± NR | 0 ± NR | NR | NR | 94.09 | 96.09 | −0.12 ± NR | NR | NR | NR |
| Current study | 0.88 ± 0.16 (decimal) | 0.96 ± 0.09 (decimal) | 1.09 | 1.00 | 90.6 | 93.9 | −0.09 ± 0.47 | 15.27 ± 3.03 (0) | 2516 ± 234 (2.04) | 320 ± 136 (96 to 603) |
UCVA: uncorrected distance visual acuity, CDVA: corrected distance visual acuity, SE: spherical equivalent, and NR: not reported.